Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
European Journal of Clinical Pharmacology|October 27, 2021
Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substancesMaximilian Gahr, Bernhard J Connemann, Rainer Muche, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 16, 2004
Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's diseaseDaniela Berg, Berthold Merz, Karlheinz Reiners, et al.Drugs - Real World Outcomes|June 12, 2021
Risk of Bleeding Associated with Antidepressant Drugs: The Competitive Impact of Antithrombotics in Quantitative Signal DetectionRené Zeiss, Christoph Hiemke, Carlos Schönfeldt-Lecuona, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 25, 2012
Low ceruloplasmin in a patient with Niemann-Pick type C diseaseBernhard J Connemann, Maximilian Gahr, Markus Schmid, et al.Journal of Clinical Psychopharmacology|June 22, 2022
Drug-Associated Liver Injury Related to Antipsychotics: Exploratory Analysis of Pharmacovigilance DataRené Zeiss, Susanne Hafner, Carlos Schönfeldt-Lecuona, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Sexual Dysfunction Induced by Antidepressants-A Pharmacovigilance Study Using Data from VigiBase<sup>TM</sup>Rene Zeiss, Kathrin Malejko, Bernhard Connemann, et al.Asian Journal of Psychiatry|January 8, 2022
The state of mental health care in ChinaZiyan Xu, Maximilian Gahr, Yutao Xiang, et al.Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|September 30, 2016
Mild Hypothermia in a Child with Low-Dose RisperidoneKatharina Grau, Paul L Plener, Maximilian Gahr, et al.Brain Sciences|November 27, 2019
Intranasal Pregabalin Administration: A Review of the Literature and the Worldwide Spontaneous Reporting System of Adverse Drug ReactionsMohamed Elsayed, René Zeiss, Maximilian Gahr, et al.Journal of Clinical Pharmacology|February 5, 2015
Hepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring CentreMaximilian Gahr, René Zeiss, Dirk Lang, et al.Pageof 8